Adjustment of Conditional Bias in Hazard Ratios for Group Sequential Testing of Progression‐Free Survival and Overall Survival
Statistics in Medicine · 2025
DOI: 10.1002/sim.70112 ↗At a glance
Journal article in Statistics in Medicine, 2025. Written by Shoki Izumi and 2 co-authors. Institution: Department of Biostatistics, Division of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Major MEDLINE topics: Randomized Controlled Trials as Topic, Progression-Free Survival. 31 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
In confirmatory randomized controlled trials of patients with metastatic cancer, progression‐free survival (PFS) and overall survival (OS) are often used as multiple primary endpoints. The overall hierarchical strategy is a typical multiplicity adjustment method that analyzes PFS once and performs an interim OS analysis at the time of PFS analysis using an alpha‐spending function—only if the statistical significance of PFS is demonstrated. A subsequent final OS analysis is conducted if the interim OS analysis does not result in early stopping for efficacy. In this study, we focused on the adjustment of conditional bias (CB) in hazard ratio estimates for OS in both interim and final analyses when a trial applied the overall hierarchical strategy. As CB‐adjusting estimators for a single primary endpoint may have limited performance, we extended the conditional mean‐adjusted estimator to the case of an overall hierarchical strategy. Motivated by an actual oncology trial, we evaluated the performance of the proposed estimators through a simulation study. In the case of early stopping for efficacy, the CB of the proposed estimator was smaller than that of the existing methods with comparable root mean squared error.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Biostatistics, Division of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Section of Biostatistics, Department of Clinical Data Science, Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, Tokyo, Japan.
- Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID profiles: Shogo Nomura
Cite
APA
Izumi, S., Nomura, S., & Matsuyama, Y. (2025). Adjustment of Conditional Bias in Hazard Ratios for Group Sequential Testing of Progression‐Free Survival and Overall Survival. Statistics in Medicine. https://doi.org/10.1002/sim.70112
Vancouver
Izumi S, Nomura S, Matsuyama Y. Adjustment of Conditional Bias in Hazard Ratios for Group Sequential Testing of Progression‐Free Survival and Overall Survival. Statistics in Medicine. 2025. doi:10.1002/sim.70112
BibTeX
@article{Izumi2025,
author = {Izumi, Shoki and Nomura, Shogo and Matsuyama, Yutaka},
title = {Adjustment of Conditional Bias in Hazard Ratios for Group Sequential Testing of Progression‐Free Survival and Overall Survival},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70112}
}
EUVIMED